课题基金 / 基金详情

Mechanisms of O6-methylguanine induced senescence and transcriptional repression in glioblastoma cells

Mechanisms of O6-methylguanine induced senescence and transcriptional repression in glioblastoma cells
O6-甲基鸟嘌呤诱导胶质母细胞瘤细胞衰老和转录抑制的机制
批准号:
398037827
负责人:
Professor Dr. Markus Christmann
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2022-12-31

项目摘要

项目成果

Professor Dr. Markus Christmann的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
An important group of genotoxic agents acts via methylation at the O6-position of guanine, giving rise to the formation of O6-methylguanine (O6MeG) in the DNA. Among these agents is the anticancer drug temozolomide (TMZ), which is used in the 1st line therapy of high-grade gliomas, notably glioblastomas. In our previous work we showed that TMZ induces in glioblastoma cells not only apoptosis and autophagy, but also senescence, which was triggered by O6MeG. In extended (unpublished) background studies we also show that senescence occurs in G2 phase cells, which is dependent on p21 activity. Since the success of glioblastoma therapy is related to the DNA repair capacity of the tumor, we addressed the question whether TMZ-induced senescence leads to alterations in DNA repair capacity. These studies showed that TMZ-induced senescence is strongly associated with transcriptional repression of the DNA repair proteins EXO1, MSH2, MSH6 und RAD51, with p21 playing a role also in this repression process. In this grant proposal we wish to analyze in two intertwined subprojects (TP1, Kaina; TP2, Christmann) the molecular mechanisms underlying TMZ-induced senescence, focusing on the role of persistent DNA damage and sustained DDR activation. Specifically we want to address the questions of a) which signaling mechanisms activated by O6MeG trigger senescence, b) what makes activation of DDR following primary DNA damage in a fraction of cells permanent, c) can sustained DDR be alleviated, d) are senescent cells prone to DNA damaging agents, e) can senescent cells regain propliferation capacity, f) is DNA repair capacity and drug sensitivity of recovered senescent cells comparable or different from parental cells that have not undergone senescence? Further we wish to study g) the molecular mechanism underlying senescence associated p21 mediated transcriptional repression of repair genes using ChiP-Seq and mass-spectrometry to find p21 interaction partners, h) whether transcriptional repression of DNA repair genes EXO1, MSH2, MSH6 und RAD51 is affected by epigenetic mechanisms, i.e. alterations in the chromatin structure or promoter hypermethylation. The experimental data will be assessed as to whether the DNA repair capacity in senescent cells can be harnessed in order to prevent their escape from the senescent state, eliminating them selectively by anticancer drug treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interplay between benzo(a)pyrene-induced senescence and transcriptonal repression of DNA repair
  • 批准号:
    388225306
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Professor Dr. Markus Christmann
  • 依托单位:
Rolle von c-Fos in der Regulation der DNA-Reparatur und der Protektion gegenüber Genotoxinen
  • 批准号:
    63792951
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Professor Dr. Markus Christmann
  • 依托单位:
Impact of HIPK2 and posttranslational p53 modification on B[a]P/BPDE induced cell death and senescence
  • 批准号:
    470145176
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professor Dr. Markus Christmann
  • 依托单位:
国内基金
海外基金
重稀土基双钙钛矿R2MM'O6中相变驱动的磁热效应增强与临界行为研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李苍龙
  • 依托单位:
Sr2BB’O6锶基双钙钛矿中B位双金属活性位的协同催化机制研究
绿脓杆菌O6血清型O-抗原四糖重复单元的全合成及其抗原性研究
  • 批准号:
    22107037
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    田光宗
  • 依托单位:
基于A2BB'O6型多铁电材料的磁性拓扑能带结构研究
  • 批准号:
    LQ21A040010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    曾宜杰
  • 依托单位: